Safety of 100 µg venom immunotherapy rush protocols in children compared to adults

There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and ...

http://ift.tt/2uQ0T2Y